Content Topics

Climate 64

View All

Deep Tech Opportunities Report

DCVC DTOR 2024: Industry is turning to unconventional water sources for fresh water and critical minerals

Deep Tech Opportunities Report

DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now

In a deep-tech twofer, Brimstone aims to secure U.S. aluminum supply

By Dr. Rachel Slaybaugh

Deep Tech Opportunities Report

DCVC DTOR 2024: New storage and generation technologies will make the electrical grid cleaner and more resilient

Computational Bio & Chem 29

View All

Company Profile

Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits

By Dr. Emily Park, Dr. Kiersten Stead

Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration

By Dr. Kiersten Stead

Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs

By Dr. Kiersten Stead

Manufacturing cancer-killing T cells inside the body

By Dr. John Hamer, Dr. Kiersten Stead

Cybersecurity, Security, & Defense 17

View All

Human identity needs a Zero Trust moment

Reality Defender democratizes deepfake detection with public API launch

Reality Defender answers FINRA call

The hard problem of hardware attacks

By James Hardiman

Enterprise Enablement 7

View All

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC companies are at the forefront of better generative AI: Databricks to acquire MosaicML for $1.3B

By Matthew Ocko

Confluent IPO: Data In (Upward) Motion

By Matthew Ocko

DCVC Announcements

2021 and Deep Tech: Reasons for Optimism

Finance & Insurance 3

View All

DCVC proud to back ElectronX in its quest to build the first-ever direct-access regulated derivatives exchange for the electric power markets

Deep Tech Opportunities Report

Cryptography for the real world

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

Foundational Technology 9

View All

Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership

By Matthew Ocko, Zachary Bogue

Quantum Advantage: Q-CTRL’s next-generation navigation system to guide us when GPS can’t

By James Hardiman

Deep Tech Opportunities Report

DCVC DTOR 2024: With quantum computing, we invest in the picks and shovels

Odyssey is delivering powerful new 3D generative AI tools to Hollywood

Industrial Transformation 31

View All

Lumafield raises $75 million to give manufacturers a look deep inside their products as they come out of the lab and off the line

By James Hardiman

Alta debuts with $5.1 million Seed to sustainably separate critical minerals using advanced biochemistry

By James Hardiman

Clearing the Docks

By James Hardiman

Climate tech’s lemons-to-lemonade moment: how the private sector can ensure a durable, clean American industrial renaissance

Smart Agriculture 16

View All

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

Deep Tech Opportunities Report

DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now

CH4 Global opens the world's first commercial-scale Asparagopsis production facility

By Zachary Bogue, Dr. Justin Kern

DCVC Announcements

DCVC closes $700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report

Space 10

View All

DCVC anchors $150 million in financing for Impulse Space to deliver precise, fast, and affordable maneuverability of satellites within and between orbits

By Matthew Ocko, Matt O'Connell

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC Announcements

DCVC Welcomes 2022

On Going to Space

TechBio 5

View All

Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells

By Jason Pontin

Deep Tech Opportunities Report

DCVC DTOR 2024: TechBio is emerging as the data-centric, AI-native counterweight to biotech

Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis

By Jason Pontin

DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases

By Jason Pontin, Zachary Bogue

TechMed 22

View All

Proprio’s latest FDA approval clears the way for better, AI-driven surgery

Proprio's Physical AI at the 2025 JPM Healthcare Conference

The Somatic AI revolution: How TechMed is reshaping healthcare as we know it

Valar Labs introduces a smarter cancer test

By James Hardiman